HCA Healthcare, Inc. has reported its financial and operating results for the third quarter ended September 30, 2025, showcasing significant growth and positive performance across various key metrics compared to the same period in 2024.
Revenues for the third quarter of 2025 increased by 9.6 percent to $19.161 billion compared to $17.487 billion in the third quarter of 2024. Net income attributable to HCA Healthcare, Inc. surged by 29.4 percent to $1.643 billion, resulting in diluted earnings per share increasing by 42.6 percent to $6.96 per diluted share.
Adjusted EBITDA, a key financial metric, rose by 18.5 percent to $3.870 billion, while cash flows from operating activities totaled $4.416 billion, up from $3.515 billion in the third quarter of 2024.
The company also saw positive growth in its operational measures, with same facility admissions increasing by 2.1 percent and same facility equivalent admissions rising by 2.4 percent. Additionally, same facility revenue per equivalent admission increased by 6.6 percent in the third quarter of 2025 compared to the same period in 2024.
For the nine months ended September 30, 2025, revenues totaled $56.087 billion, up from $52.318 billion in the prior year period. Net income attributable to HCA Healthcare, Inc. for the first nine months of 2025 was $4.906 billion, or $20.23 per diluted share, compared to $4.322 billion, or $16.37 per diluted share, for the same period in 2024.
HCA Healthcare, Inc.’s balance sheet as of September 30, 2025, reflected cash and cash equivalents of $997 million, total debt of $44.511 billion, and total assets of $59.747 billion. The company also repurchased 6.514 million shares of its common stock at a cost of $2.498 billion during the third quarter of 2025.
Looking ahead, the company raised its 2025 estimated guidance ranges, with revised figures for revenues, net income attributable to HCA Healthcare, Inc., adjusted EBITDA, and diluted earnings per share. The updated guidance reflects the company's optimistic outlook for the remainder of the year.
These results indicate a strong financial performance by HCA Healthcare, Inc., driven by revenue growth, improved operational metrics, and enhanced earnings, positioning the company for continued success in the healthcare industry. The market has reacted to these announcements by moving the company's shares -0.23% to a price of $440.16. For the full picture, make sure to review HCA Healthcare's 8-K report.
